Actual costs may be lower with private insurance, Medicare, or savings programs, if prescribed for diabetes, heart, or kidney conditions
Symptoms that warrant medical attention include severe or persistent headaches beyond one week, significant digestive distress, dizziness that doesn't resolve, skin rashes or allergic reactions, or any symptom that feels concerning for your body
The GLP-1 component GLP-1, or glucagon-like peptide-1, is an incretin hormone released from intestinal L-cells after eating
10.1007/s12035-021-02720-3 Mol
Probably not if you have a clinical indication now
The injection has been approved by the FDA to manage Type II diabetes and chronic weight management in adults with obesity and is administered once weekly (1-5)